Day 1 - Friday, 30 June 2017
Meeting category
Date(s)
30 Jun 2017 - 1 Jul 2017
Location
Santiago,
Chile
Organizer
Platinum Level Support
Sponsor logos
Andean Pacific Workshop on HIV & Hepatitis 2017
Related Enduring Materials
Enduring Materials
Program
Session 1: Challenges for HIV care in Latin America -
HIV in Latin America: 35 years later
WHO Target 90-90-90 : Achievable for Latin America
Difficult to reach populations in Latin America
Session 2: Prevention to transmission -
New approaches for preventing transmission
State-of-the-art lecture on PrEP
Session 3: Clinical strategies -
Clinical Implications of low level viremia/ failure and resistance
Abstract presentations
Proviral DNA as a Target for HIV-1 Resistance Analysis
Transmitted Drug Resistance in HIV-Infected Treatment-Naïve Patients in Chile between 2014 and 2017
Transmitted HIV Resistance in ART-Naïve Patients, Colombia (not available)
Dr. Galindo-Orrego
Taller Latinoamericano, Bogotá, Colombia
Risk factors for virologic failure in a cohort of patients with HIV in Colombia (coming soon)
Dr. Del Carmen Figueredo Pena
University Hospital San Ignacio, Bogotá, Colombia
Session 4: Diagnostic tools -
Early diagnosis & testing
Abstract presentations
Risk profiles for HIV transmission and HIV status in MSM versus heterosexual men populations in the South West of Colombia.
Moving forward to 90-90-90: Analysis of a cohort of recently-diagnosed patients in a tertiary hospital in Buenos Aires, Argentina.
High rates of retention on ART and virological suppression in a large cohort study from The Chilean AIDS Group
Day 2 - Saturday, 1 July 2017
Session 5: Viral hepatitis in Latin America -
Mark Nelson, MA, MBBS, FRCP
Local situation in LA (epidemiology / treatment options)
Implementation of DAAs in clinical management
Chelsea and Westminster Hospital / Imperial College Medical School, United Kingdom
Strategies for hepatitis C elimination
Session 6: Special Populations -
HIV- hepatitis co-infected patients
HIV in Women - PTMCT - pregnancy
The aging HIV infected patient - neurological issues - poly pharmacy
Session 7: ARV Therapy: present and future -
Mark Nelson, MA, MBBS, FRCP
Do we really need new drugs?
Chelsea and Westminster Hospital / Imperial College Medical School, United Kingdom
Present and future of ART in Latin America
HIV cure and eradication
Overview
Committees
Support
